Funke G, Ramos C P, Fernández-Garayzábal J F, Weiss N, Collins M D
Department of Medical Microbiology, University of Zürich, Switzerland.
Int J Syst Bacteriol. 1995 Jan;45(1):57-60. doi: 10.1099/00207713-45-1-57.
Biochemical, chemotaxonomic, and molecular methods were used to establish the precise taxonomic position of the Centers for Disease Control (CDC) coryneform group 2 bacteria. The results of a comparative 16S rRNA sequence analysis demonstrated that the CDC coryneform group 2 bacteria constitute a distinct species within the genus Actinomyces. Actinomyces pyogenes was found to be the closest genealogical relative of the CDC coryneform group 2 bacteria, although these taxa were readily distinguished from each other and other Actinomyces spp. by using phenotypic criteria. On the basis of our findings we propose the name Actinomyces bernardiae sp. nov. for the CDC coryneform group 2 bacteria. The type strain is DSM 9152 (CCUG 33419).
采用生化、化学分类学和分子方法来确定疾病控制中心（CDC）棒状杆菌属第2群细菌的确切分类地位。16S rRNA序列比较分析结果表明，CDC棒状杆菌属第2群细菌构成放线菌属内一个独特的种。化脓放线菌被发现是CDC棒状杆菌属第2群细菌最接近的谱系亲缘菌，不过通过表型标准，这些分类单元很容易相互区分，也能与其他放线菌属菌种区分开来。基于我们的研究结果，我们提议将CDC棒状杆菌属第2群细菌命名为伯纳德放线菌（Actinomyces bernardiae sp. nov.）。模式菌株为DSM 9152（CCUG 33419）。
